Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors Read more about Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors Japan2018-521518Filed on 2016-10-31
Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors Read more about Compositions and Methods for the Treatment of HER2-Expressing Solid Tumors Canada3002685Filed on 2016-10-31
HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Read more about HUMAN MONOCLONAL ANTIBODY TARGETING TNFR2 FOR CANCER IMMUNOTHERAPY Patent Cooperation TreatyPCT/US2018/031618Filed on 2018-05-08
Process For Preparing Z-endoxifen Of High Purity Read more about Process For Preparing Z-endoxifen Of High Purity US Patent 10,464,881Filed on 2018-04-23
Process For Preparing Z-Endoxifen Of High Purity Read more about Process For Preparing Z-Endoxifen Of High Purity European Patent16798855.9Filed on 2016-10-24
AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE Read more about AGENTS AND METHODS TO ELICIT ANTI-TUMOR IMMUNE RESPONSE US Patent 10,421,945Filed on 2018-03-19
Anti-CD30 Chimeric Antigen Receptors Read more about Anti-CD30 Chimeric Antigen Receptors Saudi Arabia518391355Filed on 2018-04-12
Anti-CD30 Chimeric Antigen Receptors Read more about Anti-CD30 Chimeric Antigen Receptors South Korea2018-7013573Filed on 2018-05-14
Anti-CD30 Chimeric Antigen Receptors Read more about Anti-CD30 Chimeric Antigen Receptors Israel258527Filed on 2018-04-08
THALIDOMIDE ANALOGS AND METHODS OF USE Read more about THALIDOMIDE ANALOGS AND METHODS OF USE US Patent 10,730,835Filed on 2018-03-28